Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Carbapenemases: a worldwide threat.

Quinn JP.

Expert Rev Anti Infect Ther. 2013 Jul;11(7):643-4. doi: 10.1586/14787210.2013.811929. No abstract available. Erratum in: Expert Rev Anti Infect Ther. 2013 Sep;11(9):977.

PMID:
23879603
[PubMed - indexed for MEDLINE]
2.

Current status of carbapenemases in Latin America.

Maya JJ, Ruiz SJ, Blanco VM, Gotuzzo E, Guzman-Blanco M, Labarca J, Salles M, Quinn JP, Villegas MV.

Expert Rev Anti Infect Ther. 2013 Jul;11(7):657-67. doi: 10.1586/14787210.2013.811924.

PMID:
23879607
[PubMed - indexed for MEDLINE]
3.

Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.

Rapp RP, Urban C.

Pharmacotherapy. 2012 May;32(5):399-407. doi: 10.1002/j.1875-9114.2012.01035.x. Epub 2012 Apr 5. Review.

PMID:
22488420
[PubMed - indexed for MEDLINE]
4.

Carbapenemases: the versatile beta-lactamases.

Queenan AM, Bush K.

Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents. Review.

PMID:
17630334
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

What should be the criteria for application of modified Hodge test for carbapenemases in Klebsiella pneumoniae?

Chande C, Veer P, Chivate A, Joshi SG, Chowdhary A.

Indian J Med Microbiol. 2013 Jul-Sep;31(3):318-9. doi: 10.4103/0255-0857.115673. No abstract available.

PMID:
23883731
[PubMed - indexed for MEDLINE]
Free Article
6.

The spread of Klebsiella pneumoniae carbapenemases: a tale of strains, plasmids, and transposons.

Munoz-Price LS, Quinn JP.

Clin Infect Dis. 2009 Dec 1;49(11):1739-41. doi: 10.1086/648078. No abstract available.

PMID:
19886796
[PubMed - indexed for MEDLINE]
Free Article
7.

What's new in antibiotic resistance? Focus on beta-lactamases.

Babic M, Hujer AM, Bonomo RA.

Drug Resist Updat. 2006 Jun;9(3):142-56. Epub 2006 Aug 8. Review.

PMID:
16899402
[PubMed - indexed for MEDLINE]
8.

First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.

Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP; Colombian Nosocomial Resistance Study Group.

Antimicrob Agents Chemother. 2006 Aug;50(8):2880-2.

PMID:
16870793
[PubMed - indexed for MEDLINE]
Free PMC Article
9.
10.

Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.

Gupta V, Bansal N, Singla N, Chander J.

J Microbiol Immunol Infect. 2013 Apr;46(2):104-8. doi: 10.1016/j.jmii.2012.01.004. Epub 2012 Apr 26.

PMID:
22541536
[PubMed - indexed for MEDLINE]
11.

Class A carbapenemases.

Walther-Rasmussen J, Høiby N.

J Antimicrob Chemother. 2007 Sep;60(3):470-82. Epub 2007 Jun 26. Review.

PMID:
17595289
[PubMed - indexed for MEDLINE]
Free Article
12.

Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?

Oelschlaeger P, Ai N, Duprez KT, Welsh WJ, Toney JH.

J Med Chem. 2010 Apr 22;53(8):3013-27. doi: 10.1021/jm9012938. No abstract available.

PMID:
20121112
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.

Tran QT, Dupont M, Lavigne JP, Chevalier J, Pagès JM, Sotto A, Davin-Regli A.

Antimicrob Agents Chemother. 2009 Apr;53(4):1652-6. doi: 10.1128/AAC.00822-08. Epub 2009 Jan 21.

PMID:
19164140
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

Panagiotakopoulou A, Daikos GL, Miriagou V, Loli A, Tzelepi E, Tzouvelekis LS.

Int J Antimicrob Agents. 2007 Mar;29(3):360-2. Epub 2007 Jan 12. No abstract available.

PMID:
17223016
[PubMed - indexed for MEDLINE]
15.

Genetic features of the widespread plasmid coding for the carbapenemase OXA-48.

Poirel L, Bonnin RA, Nordmann P.

Antimicrob Agents Chemother. 2012 Jan;56(1):559-62. doi: 10.1128/AAC.05289-11. Epub 2011 Nov 14.

PMID:
22083465
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.

Chudácková E, Bergerová T, Fajfrlík K, Cervená D, Urbásková P, Empel J, Gniadkowski M, Hrabák J.

FEMS Microbiol Lett. 2010 Aug 1;309(1):62-70. doi: 10.1111/j.1574-6968.2010.02016.x. Epub 2010 May 17.

PMID:
20528936
[PubMed - indexed for MEDLINE]
17.

Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases.

Louie A, Castanheira M, Liu W, Grasso C, Jones RN, Williams G, Critchley I, Thye D, Brown D, Vanscoy B, Kulawy R, Drusano GL.

Antimicrob Agents Chemother. 2012 Jan;56(1):258-70. doi: 10.1128/AAC.05005-11. Epub 2011 Oct 24.

PMID:
22024819
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.

Hawser SP, Bouchillon SK, Hoban DJ, Hackel M, Johnson JL, Badal RE.

Int J Antimicrob Agents. 2009 Oct;34(4):384-5. doi: 10.1016/j.ijantimicag.2009.05.010. Epub 2009 Jun 27. No abstract available.

PMID:
19560904
[PubMed - indexed for MEDLINE]
19.

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

Daikos GL, Markogiannakis A.

Clin Microbiol Infect. 2011 Aug;17(8):1135-41. doi: 10.1111/j.1469-0691.2011.03553.x. Epub 2011 Jun 2. Review.

PMID:
21635663
[PubMed - indexed for MEDLINE]
20.

[Carbapenemases in enterobacteriaceae].

Nordmann P, Carrer A.

Arch Pediatr. 2010 Sep;17 Suppl 4:S154-62. doi: 10.1016/S0929-693X(10)70918-0. French.

PMID:
20826325
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk